MedPath

Rabbit

Generic Name
Rabbit
Drug Type
Biotech
Unique Ingredient Identifier
O5V0F26RUW

Overview

Rabbit allergenic extract is used in allergenic testing.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
2023/12/06
NCT06158828
Phase 1
Recruiting
Washington University School of Medicine
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
2022/10/31
NCT05600426
Phase 3
Recruiting
Boston Children's Hospital
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
2022/05/23
NCT05385432
Phase 3
Not yet recruiting
University Hospital, Tours
Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy
2022/01/20
NCT05199103
Not Applicable
UNKNOWN
Medical University of Silesia
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
2020/03/31
NCT04328727
Phase 2
Completed
Novartis Pharmaceuticals
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
2019/06/10
NCT03980769
Phase 2
Recruiting
Fred Hutchinson Cancer Center
Veloxis de Novo Kidney Transplant ECSWD
2019/02/04
NCT03828682
Phase 4
UNKNOWN
Simon Tremblay, PharmD, PhD
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
2018/01/08
NCT03393611
Phase 1
Completed
Weill Medical College of Cornell University
A Blood Stem Cell Transplant for Sickle Cell Disease
2017/08/15
NCT03249831
Phase 1
Active, not recruiting
City of Hope Medical Center
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
2016/10/18
NCT02936505
Not Applicable
Active, not recruiting
Vastra Gotaland Region

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Rabbit Meat
Antigen Laboratories, Inc.
49288-0437
SUBCUTANEOUS, INTRADERMAL
0.05 g in 1 mL
11/13/2009

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
THYMOGLOBULINE rabbit antithymocyte immunoglobulin powder for solution for infusion vial
139787
Sanofi-Aventis Australia Pty Ltd
Medicine
A
7/18/2008

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy